Literature DB >> 11353598

Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series.

K N Roy Chengappa1, J Levine, D Rathore, H Parepally, R Atzert.   

Abstract

Topiramate is an antiepileptic agent, which is being investigated as a mood-stabilizer. Three obese individuals with DSM-IV bipolar I disorder and type II diabetes mellitus received topiramate treatment in combination with antipsychotics and valproate or carbamazepine. In addition to improved mood stability, these individuals lost between 16 to 20.5% of their pre-topiramate body weight and also achieved significant glycemic control.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353598     DOI: 10.1016/s0924-9338(01)00562-4

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  19 in total

Review 1.  Antiobesity drugs: current and future issues.

Authors:  M Ammar Hatahet; Nikhil V Dhurandhar
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 2.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Improvement of cervico-trunco-brachial segmental dystonia with topiramate.

Authors:  Spiridon Papapetropoulos; Carlos Singer
Journal:  J Neurol       Date:  2005-11-22       Impact factor: 4.849

4.  Differential effects of topiramate in patients with traumatic brain injury and obesity--a case series.

Authors:  Ornah T Dolberg; Gaby Barkai; Yigal Gross; Shaul Schreiber
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 5.  Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.

Authors:  Bankole A Johnson; Nassima Ait-Daoud
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

6.  Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice.

Authors:  Tulin O Price; Vijay Eranki; William A Banks; Nuran Ercal; Gul N Shah
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

Review 7.  Psychotropic drugs in the treatment of obesity: what promise?

Authors:  Jose C Appolinario; João R Bueno; Walmir Coutinho
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 8.  Preventive treatment of migraine: effect on weight.

Authors:  William B Young
Journal:  Curr Pain Headache Rep       Date:  2008-06

Review 9.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

Review 10.  Safety and tolerability of lamotrigine for bipolar disorder.

Authors:  Charles L Bowden; Gregory M Asnis; Lawrence D Ginsberg; Beth Bentley; Robert Leadbetter; Robin White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.